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unchanged during the study protocol. patients allocated to the fM 
group received 5 sessions of 30-45 minutes, 1 session per week 
for 5 weeks. the most dysfunctional cc’s and cf’s, in the hand, 
forearm, arm, chest, and neck, were submitted to a comparative 
palpation following the fM guidelines.2 after the selection of the 
points, friction was applied for 2 to 4 minutes.7 patients allocated 
to the sham group received the exact same protocol except that the 
frictions were applied outside the points used in the fM method. 
duration of treatment was equal in both groups. clinical outcomes 
encompassed the Visual analog scale (Vas),8 both the symptom 
severity subscale (bs) and the functional status subscale (bf) of 
the boston carpal tunnel Questionnaire (bctQ, brazilian transla-
tion),9 and the disability of the arm shoulder and hand (dash) 
scale.10 all evaluations were performed at baseline (t0), ten days 
(t1) and three months after the last treatment session (t2). Elec-
tromyographic median nerve conduction velocity and latency were 
also recorded at t0 and t1. patients and assessors were blinded 
from the allocated treatment. patients were randomized into two 
treatment groups: fascial Manipulation (n.=7) and sham manipu-
lation (N.=7). We first used paired t-test to compare fM versus 
sham groups at the end of treatment for all assessments. the effect 
size (cohen’s d effect size) was calculated from the difference in 
values between baseline (t0) and post-treatment (t1) comparing 
fM with sham. We then conducted a one-way analyses of variance 
(anoVa) to compared the longitudinal effect of treatment (real 
versus sham) on the absolute change (i.e., delta, which equals to 
post-treatment minus pre-treatment values) to account for baseline 
differences, at t1 (i.e., scores at t1 minus scores at t0) and at t2 
(i.e., scores at t2 minus scores at t0). for every analysis, the sig-
nificance level was set at P<0.05. Although this was a pilot study, 
we did estimate a sample size considering the results of a previous 
study.6 Using an effect estimate of 0.91, α level at P=0.05, and 
power was of 80%, power analysis indicated that 7 participants per 
group would provide sufficient power.
no side effects were reported for any of the patients. patients’ 
baseline characteristics can be found in supplementary table i. 
When analyzing the main endpoint and comparing both groups, 
we found a significant difference at T1 for the BS (P=0.021; effect 
size: 1.04) and a trend for bf (p=0.051; effect size: 1.11). none of 
the other scales, neither electromyographic measurements, dem-
onstrated any significant differences between the groups at T1 
(Table I). When analyzing the longitudinal effects, we did not find 
a significant interaction for group vs. time for any of the scales 
(p>0.05) (supplementary table ii).
Even considering this study as a pilot study, we identified a sig-
nificant effect of FM in patients with CTS after 5 weeks of treat-
ment. the effect size was also bigger than the one we expected 
(1.11 versus 0.91). These findings provide additional data support-
ing the efficacy of FM in improving CTS patients’ symptoms. This 
technique has the advantage to be safe, with no adverse event and 
needs to be applied once a week. however, it should be underlined 
that the effects did not last over time. therefore, further trials trying 
to optimize the methods and including a bigger sample size should 
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Evaluation of fascial manipulation 
in carpal tunnel syndrome: 
a pilot randomized clinical trial
dear Editor,
carpal tunnel syndrome (cts) is the most common nerve com-
pression syndrome, accounting for 90% of all compressive neuropa-
thies.1 despite its high incidence, cts remains challenging to treat. 
fascial manipulation (fM) 2 involves deep friction over specific 
points, namely the center of coordination (cc) and the center of fu-
sion (cf), i.e., where the vector forces of the myofascial expansions 
of synergic muscles occur (figure 1). this technique has demon-
strated to reduce pain symptoms in other musculoskeletal conditions 
such as painful shoulder syndrome,3 patellar tendinopathy 4 or post 
traumatic neck pain.5 a recent study comparing fM to conventional 
laser therapy in cts showed that fM had better effects than laser 
therapy on pain relief and disability of the upper limb.6 however, 
there was no sham comparator, and therefore we cannot disentangle 
the effects of the intervention from a placebo effect. in the present 
pilot study, we aimed to assess the efficacy of FM applied over the 
ccs and cfs compared to a sham intervention that looks like fM but 
applied over other areas of the skin, in patients with cts.
the study was approved by the Ethics committee of the insti-
tute of physical Medicine and rehabilitation, sao paulo, brazil. 
patients signed an informed consent according the declaration of 
helsinki. registration number: nct02495298. fourteen women 
(age: 18-65 years old) were enrolled and completed the trial. be-
fore starting the treatment, all patients received an educational pro-
gram regarding appropriate behaviors to avoid upper limbs over-
use or incorrect movements during daily activities together with 
an exercise program to complete at home. Medication was kept 
L E T T E R S  T O  T H E  E D I T O R
figure 1.—treated centers of coordination.
an: antemotion; rE: retromotion; la: lateromotion; ME: mediomo-
tion; ir: intrarotation; Er: extrarotation.
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be performed. interestingly, the bctQ was the only measurement 
able to capture a difference between the real and the sham inter-
ventions. overall, this scale can be considered as the most accurate 
questionnaire that reflects patients’ improvement. As compared to 
the Vas and the dash, the bctQ requires more objective reports 
(e.g., by giving specific tasks to evaluate) from patients and there-
fore, is less likely to be affected by patients’ expectations.
in conclusion, the results of this pilot study do underscore the 
need to perform randomized clinical trials to understand the real 
effect of fM. although results were positive, they do need to be 
replicated in larger studies. further clinical trials should also pow-
er the study to detect long lasting effects. in this trial, the effect 
sizes at t2 for bs and bf were 0.62 and 0.79 respectively; thus, 
larger clinical trials should consider smaller effect sizes when de-
signing the protocol. We also suggest that bcQt may be the best 
outcome to detect the effects of fM in patients with cts.
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Table I.—Results of the t-tests for the VAS, the BS and FB of the BCTQ, and the DASH.
Variable fM sham t p value cohen’s d effect size
Vas t0 7.29±1.78 7.90±1.55 0.69 0.503
Vas t1 2.50±2.18 3.71±1.25 -1.28 0.225 0.21
Vas t2 2.29±2.23 4.00±3.37 -1.12 0.284 0.35
bs t0 3.40±1.00 3.38±0.50 0.06 0.952
bs t1 1.71±0.76 2.83±0.82 -2.65 0.021* 1.04
bs t2 1.94±0.89 2.56±00.66 -1.48 0.166 0.62
bf t0 3.46±0.99 3.29±0.44 0.43 0.672
bf t1 1.75±1.14 2.86±0.74 -2.17 0.051† 1.11
bf t2 2.00±1.02 2.79±1.23 -1.29 0.219 0.79
dash t0 66.96±10.02 51.79±24.40 -1.52 0.154
dash t1 40.17±29.94 53.57±17.25 1.03 0.325 0.55
dash t2 40.17±33.24 45.53±32.41 0.30 0.765 0.15
Vas: Visual analog scale; bs: symptom severity subscale of the boston carpal tunnel Questionnaire (brazilian translation); bf: functional status subscale of the 
boston carpal tunnel Questionnaire (brazilian translation); dash: disability of the arm shoulder and hand scale.
*Significant P value (>0.05); †trend to significance (P=0.051).
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SUPPLEMENTARY MATERIALS
SupplemenTary Table II.—ANOVA results for the VAS, BCTQ (BS 
and BF) and the DASH.
tools Statistical significance
Vas
Group (t1-t0) F=0.15; p=0.701
Group (t2-t0) F=0.43; p=0.526
bs
Group (t1-t0) F=3.78; p=0.076
Group (t2-t0) F=1.33; p=0.271
bf
Group (t1-t0) F=4.33; p=0.059
Group (t2-t0) F=2.2; p=0.164
dash
Group (t1-t0) F=0.12; p=0.738
Group (t2-t0) F=0.12; p=0.738
Vas: Visual analog scale; bs: symptom severity subscale of the boston carpal 
tunnel Questionnaire (brazilian translation); bf: functional status subscale of 
the boston carpal tunnel Questionnaire (brazilian translation); dash: disability 
of the arm shoulder and hand scale.
SupplemenTary Table I.—Characteristics of included patients at 
baseline.
Variables fM (n.=7) sham (n.=7) p value
age, years 53±10.21 49.85±10.30 0.984
affected side, left (%) 5 (71.4%) 2 (28.57%) 0.109
Weight, kg 79.1±29.65 69.35±9.16 0.012
height, cm 1.61±0.09 1.56±0.04 0.119
duration of pain before treatment, 
months
38.57±38.55 29.14±16.40 0.057
Vas 7.29±1.78 7.90±1.55 0.503
bs 3.40±1.00 3.38±0.50 0.952
bf 3.46±0.99 3.29±0.44 0.672
dash scale 66.96±10.02 51.79±24.40 0.154
Data are presented as mean±SD, where not otherwise specified.
Vas: Visual analog scale; bs: symptom severity subscale of the boston carpal 
tunnel Questionnaire (brazilian translation); bf: functional status subscale of 
the boston carpal tunnel Questionnaire (brazilian translation); dash: disability 
of the arm shoulder and hand scale.
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